In conclusion, this study reveals the oncogenic role of FMR1 in gastric cancer and demonstrates that it promotes cell proliferation, migration, and invasion via the c-MYC pathway, providing new insights into FMR1 as a potential therapeutic target for gastric cancer. This evidence concerns the gene MYC and gastric cancer.